Associated Papers
Type 2 diabetes-associated variants of the MT2 melatonin receptor affect distinct modes of signaling.
Karamitri A et al.
Science Signaling, 2018
Rational design of non-resistant targeted cancer therapies.
Martínez-Jiménez F et al.
Scientific Reports, 2017
ERK mutations confer resistance to mitogen-activated protein kinase pathway inhibitors.
Goetz EM et al.
Cancer Research, 2014
Select a paper to view details